vs

Side-by-side financial comparison of Fresenius Medical Care AG (FMS) and Kyndryl Holdings, Inc. (KD). Click either name above to swap in a different company.

Fresenius Medical Care AG is the larger business by last-quarter revenue ($5.5B vs $3.9B, roughly 1.4× Kyndryl Holdings, Inc.). Fresenius Medical Care AG runs the higher net margin — 7.9% vs 1.5%, a 6.5% gap on every dollar of revenue. On growth, Kyndryl Holdings, Inc. posted the faster year-over-year revenue change (3.1% vs -0.3%).

Fresenius Medical Care AG & Co. KGaA is a German healthcare company which provides kidney dialysis services through a network of 4,171 outpatient dialysis centers, serving 345,425 patients. The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo dialysis 3 times per week for the rest of their lives.

Kyndryl Holdings, Inc. is an American multinational information technology infrastructure services provider, headquartered in New York City and created from the spin-off of IBM's infrastructure services business in 2021. The company designs, builds, manages and develops large-scale information systems. The company also has business advisory services. It is currently the world's largest IT infrastructure services provider, and the fifth-largest consulting provider.

FMS vs KD — Head-to-Head

Bigger by revenue
FMS
FMS
1.4× larger
FMS
$5.5B
$3.9B
KD
Growing faster (revenue YoY)
KD
KD
+3.4% gap
KD
3.1%
-0.3%
FMS
Higher net margin
FMS
FMS
6.5% more per $
FMS
7.9%
1.5%
KD

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
FMS
FMS
KD
KD
Revenue
$5.5B
$3.9B
Net Profit
$434.2M
$57.0M
Gross Margin
27.4%
21.8%
Operating Margin
11.7%
2.4%
Net Margin
7.9%
1.5%
Revenue YoY
-0.3%
3.1%
Net Profit YoY
240.4%
-73.5%
EPS (diluted)
$0.25

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FMS
FMS
KD
KD
Q4 25
$5.5B
$3.9B
Q3 25
$3.7B
Q2 25
$3.7B
Q1 25
$3.8B
Q4 24
$5.5B
$3.7B
Q3 24
$3.8B
Q2 24
$3.7B
Q1 24
$3.9B
Net Profit
FMS
FMS
KD
KD
Q4 25
$434.2M
$57.0M
Q3 25
$68.0M
Q2 25
$56.0M
Q1 25
$69.0M
Q4 24
$127.6M
$215.0M
Q3 24
$-43.0M
Q2 24
$11.0M
Q1 24
$-45.0M
Gross Margin
FMS
FMS
KD
KD
Q4 25
27.4%
21.8%
Q3 25
21.5%
Q2 25
21.3%
Q1 25
21.7%
Q4 24
25.0%
20.4%
Q3 24
19.9%
Q2 24
21.5%
Q1 24
18.6%
Operating Margin
FMS
FMS
KD
KD
Q4 25
11.7%
2.4%
Q3 25
2.6%
Q2 25
2.5%
Q1 25
3.1%
Q4 24
5.1%
6.9%
Q3 24
-0.1%
Q2 24
1.7%
Q1 24
-0.1%
Net Margin
FMS
FMS
KD
KD
Q4 25
7.9%
1.5%
Q3 25
1.8%
Q2 25
1.5%
Q1 25
1.8%
Q4 24
2.3%
5.7%
Q3 24
-1.1%
Q2 24
0.3%
Q1 24
-1.2%
EPS (diluted)
FMS
FMS
KD
KD
Q4 25
$0.25
Q3 25
$0.29
Q2 25
$0.23
Q1 25
$0.30
Q4 24
$0.89
Q3 24
$-0.19
Q2 24
$0.05
Q1 24
$-0.19

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FMS
FMS
KD
KD
Cash + ST InvestmentsLiquidity on hand
$1.7B
$1.3B
Total DebtLower is stronger
$2.3B
Stockholders' EquityBook value
$15.4B
$1.2B
Total Assets
$33.5B
$11.3B
Debt / EquityLower = less leverage
1.92×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FMS
FMS
KD
KD
Q4 25
$1.7B
$1.3B
Q3 25
$1.3B
Q2 25
$1.5B
Q1 25
$1.8B
Q4 24
$1.3B
$1.5B
Q3 24
$1.3B
Q2 24
$1.3B
Q1 24
$1.6B
Total Debt
FMS
FMS
KD
KD
Q4 25
$2.3B
Q3 25
$3.0B
Q2 25
$3.0B
Q1 25
$3.0B
Q4 24
$3.1B
Q3 24
$3.1B
Q2 24
$3.1B
Q1 24
$3.1B
Stockholders' Equity
FMS
FMS
KD
KD
Q4 25
$15.4B
$1.2B
Q3 25
$1.2B
Q2 25
$1.2B
Q1 25
$1.2B
Q4 24
$17.0B
$1.1B
Q3 24
$1.1B
Q2 24
$996.0M
Q1 24
$1.0B
Total Assets
FMS
FMS
KD
KD
Q4 25
$33.5B
$11.3B
Q3 25
$11.2B
Q2 25
$11.5B
Q1 25
$10.5B
Q4 24
$36.3B
$9.9B
Q3 24
$10.4B
Q2 24
$10.2B
Q1 24
$10.6B
Debt / Equity
FMS
FMS
KD
KD
Q4 25
1.92×
Q3 25
2.45×
Q2 25
2.44×
Q1 25
2.50×
Q4 24
2.81×
Q3 24
2.92×
Q2 24
3.12×
Q1 24
3.07×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FMS
FMS
KD
KD
Operating Cash FlowLast quarter
$2.9B
$428.0M
Free Cash FlowOCF − Capex
$208.0M
FCF MarginFCF / Revenue
5.4%
Capex IntensityCapex / Revenue
5.7%
Cash ConversionOCF / Net Profit
6.67×
7.51×
TTM Free Cash FlowTrailing 4 quarters
$299.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FMS
FMS
KD
KD
Q4 25
$2.9B
$428.0M
Q3 25
$146.0M
Q2 25
$-124.0M
Q1 25
$581.0M
Q4 24
$2.6B
$260.0M
Q3 24
$149.0M
Q2 24
$-48.0M
Q1 24
$145.0M
Free Cash Flow
FMS
FMS
KD
KD
Q4 25
$208.0M
Q3 25
$17.0M
Q2 25
$-267.0M
Q1 25
$341.0M
Q4 24
$151.0M
Q3 24
$15.0M
Q2 24
$-170.0M
Q1 24
$-57.0M
FCF Margin
FMS
FMS
KD
KD
Q4 25
5.4%
Q3 25
0.5%
Q2 25
-7.1%
Q1 25
9.0%
Q4 24
4.0%
Q3 24
0.4%
Q2 24
-4.5%
Q1 24
-1.5%
Capex Intensity
FMS
FMS
KD
KD
Q4 25
5.7%
Q3 25
3.5%
Q2 25
3.8%
Q1 25
6.3%
Q4 24
2.9%
Q3 24
3.6%
Q2 24
3.3%
Q1 24
5.2%
Cash Conversion
FMS
FMS
KD
KD
Q4 25
6.67×
7.51×
Q3 25
2.15×
Q2 25
-2.21×
Q1 25
8.42×
Q4 24
20.20×
1.21×
Q3 24
Q2 24
-4.36×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FMS
FMS

Segment breakdown not available.

KD
KD

Principal Markets Segment$1.4B37%
United States Segment$958.0M25%
Strategic Markets Segment$905.0M23%
Other$568.0M15%

Related Comparisons